30.1.2024
Cancer is one of the leading causes of morbidity and death, worldwide. Approximately 18 million people are diagnosed with cancer each year and the number is expected to increase. Pain is experienced by two thirds of patients having advanced, metastatic or terminal disease (1). Other symptoms caused by compression on…
Articles
8.8.2023
This is a webinar that you don’t want to miss! You’ll hear from an actual user and their clinical experience with MVision’s AI-powered software. Please join us as our guest speaker, Ryan Schurr from UMC in Lubbock, Texas, presents his experience with MVision AI and how MVision enhanced UMC’s…
Webinars and Videos
5.6.2023
The annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) took place in Vienna from 12 to 15 May, gathering over 6000 professionals. More than 2500 abstracts on radiotherapy-related research projects were spread among 197 sessions. May was also cancer research month and international women’s health month. Since…
11.4.2023
More than half a million people are diagnosed each year with esophageal cancer. It is the 8th most common cancer type and places sixth regarding mortality[1]. Several factors influence the treatment decision with this cancer diagnosis, like the stage of the disease, the tumor site, the pathological type, and the…
23.3.2023
HELSINKI, Finland - March 23, 2023 MVision AI raises 5.4M€ to make same-day cancer treatment the new standard MVision AI is the first cloud-based AI-powered radiotherapy planning solution for treating cancer. MVision uses artificial intelligence to automate cancer treatments with its unique automatic segmentation tool. The next-generation technology speeds up…
Press Releases
20.1.2023
MVision AI not only provides unique AI-powered solutions for Radiotherapy treatment planning but also follows the highest standards of data protection for clinics and their patients. This is of utmost importance to us so we are very excited to celebrate Data Privacy Week and explain how we protect your data…
31.5.2022
Helsinki, 31st of May, 2022 - MVision AI announces that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guideline-based, AI-powered software for automatic segmentation for radiotherapy. (more…)
News, Press Releases
29.12.2021
2021 is an innovative and foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…
News
24.8.2021
During 2020, there were over 60,000 new cancer cases and over 19,000 cancer-related deaths in Switzerland. In fact, Switzerland’s Federal Statistics Office found that, “more than one in five persons develops cancer before the age of 70.” The rates of ovarian cancer in the Swiss population have been increasing. A…
Subscribe to get information, latest news and other interesting offers about MVision AI
